Basics AquaBounty Technologies, Inc. AquaBounty Technologies Inc is a biotechnology company. The company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins. IPO Date: January 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $2.52M Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 3.94% Avg Daily Range (30 D): $0.04 | 4.90% Avg Daily Range (90 D): $0.03 | 4.33% Institutional Daily Volume Avg Daily Volume: .49M Avg Daily Volume (30 D): 1.57M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 190 Avg Trade Size (Sh.) (30 D): 413 Avg Trade Size (Sh.) (90 D): 422 Institutional Trades Total Inst.Trades: 125 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.13M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 21.76K         News May 15, 2024 @ 2:20 PM AquaBounty Technologies, Inc. (AQB) Reports Q1 Los... Source: Zacks Equity Research May 14, 2024 @ 1:10 PM Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Reve... Source: Zacks Equity Research May 13, 2024 @ 9:10 PM Cara Therapeutics (CARA) Reports Q1 Loss, Misses R... Source: Zacks Equity Research May 8, 2024 @ 9:45 PM Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, To... Source: Zacks Equity Research Oct 16, 2023 @ 12:47 PM Why ContraFect Shares Are Trading Higher By Around... Source: Lisa Levin Financials   TTM Q4 2024 FY 2024 Basic EPS $-38.65 $-21.78 $-38.65 Diluted EPS $-38.65 $-21.78 $-38.65 Revenue $ M $ -.71M $ M Gross Profit $ $ $ Net Income / Loss $ -149.19M $ -84.12M $ -149.19M Operating Income / Loss $ -111.44M $ -48.61M $ -111.44M Cost of Revenue $ $ $ Net Cash Flow $ -8.97M $ -.27M $ -8.97M PE Ratio     Splits Oct 16, 2023:   20:1 Jan 05, 2017:   30:1